Unrevealing the Epigenetic Landscape: SOX-2 and OCT-4 methylation in acute myeloid leukemia and myelodysplastic neoplasm
Discoveries · 31.05.2026 · 14 (2) · e229
DOI: 10.15190/d.2026.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discoveries, online erschienen am 31.05.2026. Verfasst von Damini Singh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Autonomous State Medical College, Hardoi, India. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Epigenetic modifications, particularly aberrant DNA methylation, play an important role in the pathogenesis of both solid and hematologic malignancies. Global hypomethylation and promoter hypermethylation can silence numerous tumor suppressor genes identified in acute myeloid leukemia (AML) and myelodysplastic neoplasm (MDS). Among stemness-associated transcription factors, OCT-4 and SOX-2 are key regulators of pluripotency and stem cell maintenance and have been implicated in cancer stem cell biology and tumor progression. Although their abnormal expression and epigenetic regulation have been reported in various malignancies, limited data are available regarding their promoter methylation status specifically in AML and MDS. Therefore, this study aimed to evaluate the methylation patterns of the transcription factors, specifically OCT-4 and SOX-2, in patients with AML and MDS. The study involved 84 newly diagnosed AML and MDS patients and 16 age, and sex-matched healthy controls. DNA was extracted from blood or bone marrow using a QIAGEN RDNA extraction kit. The SOX-2 and OCT-4 genes were studied using PCR-specific primers for methylated and unmethylated targets. SOX-2 gene methylation was observed in a significantly higher proportion of AML (n=48/77) and MDS (n=4/7) as compared to Controls (n=3/16) (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Autonomous State Medical College, Hardoi, India.
- Department of Clinical Hematology, King George's Medical University, Lucknow, India.
- Department of Pathology, King George's Medical University, Lucknow, India.
- Precision Medicine Unit, Department of Critical Care Medicine, King George's Medical University, Lucknow, UP, India.
Zitieren
APA
Singh, D., Kumar, M., Yadav, G., Singh, U. S., Prakash, S., Kushwaha, R., Jain, M., & Verma, S. P. (2026). Unrevealing the Epigenetic Landscape: SOX-2 and OCT-4 methylation in acute myeloid leukemia and myelodysplastic neoplasm. Discoveries, 14(2), e229. https://doi.org/10.15190/d.2026.8
Vancouver
Singh D, Kumar M, Yadav G, Singh US, Prakash S, Kushwaha R, et al. Unrevealing the Epigenetic Landscape: SOX-2 and OCT-4 methylation in acute myeloid leukemia and myelodysplastic neoplasm. Discoveries. 2026;14(2):e229. doi:10.15190/d.2026.8
BibTeX
@article{Singh2026,
author = {Singh, Damini and Kumar, Manish and Yadav, Geeta and Singh, Uma Shankar and Prakash, Shantanu and Kushwaha, Rashmi and Jain, Mili and Verma, Shailendra Prasad},
title = {Unrevealing the Epigenetic Landscape: SOX-2 and OCT-4 methylation in acute myeloid leukemia and myelodysplastic neoplasm},
journal = {Discoveries},
year = {2026},
volume = {14},
number = {2},
pages = {e229},
doi = {10.15190/d.2026.8}
}
EUVIMED